Jon Oxley

6.7k total citations
54 papers, 1.1k citations indexed

About

Jon Oxley is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jon Oxley has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 11 papers in Oncology. Recurrent topics in Jon Oxley's work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Urologic and reproductive health conditions (10 papers). Jon Oxley is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Urologic and reproductive health conditions (10 papers). Jon Oxley collaborates with scholars based in United Kingdom, Canada and Germany. Jon Oxley's co-authors include David Gillatt, Raj Persad, Jessica Charlet, Catherine D. Nobes, Shereen Kadir, Jonathan W. Astin, Jennifer Batson, Marialena Trivella, Sebastian Oltean and Michael Ladomery and has published in prestigious journals such as Journal of Clinical Oncology, Nature Cell Biology and Oncogene.

In The Last Decade

Jon Oxley

53 papers receiving 1.1k citations

Peers

Countries citing papers authored by Jon Oxley

Since Specialization

Citations

This map shows the geographic impact of Jon Oxley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Oxley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Oxley more than expected).

Fields of papers citing papers by Jon Oxley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Oxley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Oxley. The network helps show where Jon Oxley may publish in the future.

Co-authorship network of co-authors of Jon Oxley

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Oxley. A scholar is included among the top collaborators of Jon Oxley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Oxley. Jon Oxley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interobserver reproducibility of a hybrid three‐tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study 2025 ·Histopathology ·Michelle R. Downes, Katherine Lajkosz, Ferrán Algaba, (unknown), Mahul B. Amin, Liang Cheng, Sangeeta Desai, Markus Eckstein, Arndt Hartmann, Antonio López-Beltrán, Sebastian Mannweiler, Maurits L. van Montfoort, Jon Oxley, Gladell P. Paner, Hemamali Samaratunga, Steven S. Shen, Joshua I. Warrick, Sean R. Williamson, Sara E. Wobker, Theodorus van der Kwast	2
2	A Rare Case of Urinary Bladder Leiomyoma Invading Urachal Remnant Managed With Robotic Partial Cystectomy 2024 ·Cureus ·(unknown), Jon Oxley, (unknown), (unknown)	1
3	Prostate cancer–Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer 2022 ·Pilot and Feasibility Studies ·(unknown), (unknown), Raj Persad, Edward Rowe, Amit Bahl, Jonathan Aning, Anthony Koupparis, Paul Abrams, Claire M. Perks, Jeffrey M P Holly, Lyndsey Johnson, Constance Shiridzinomwa, Amarnath Challapalli, (unknown), Hilary Taylor, Jon Oxley, (unknown), Richard M. Martin, J. Athene Lane	2
4	A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder 2021 ·Clinical Genitourinary Cancer ·Amarnath Challapalli, (unknown), Paul White, (unknown), S.K. Pearson, Edward Rowe, Anthony Koupparis, Jon Oxley, (unknown), (unknown), Alicia Bravo, Emily Foulstone, Claire M. Perks, Jeff M.P. Holly, Raj Persad, Amit Bahl	4
5	Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer 2021 ·Cancers ·(unknown), Kalina Biernacka, (unknown), (unknown), Rachel Barker, Hanna Zielińska, Amanda Gilkes, Kathryn McCarthy, Richard M. Martin, J. Athene Lane, (unknown), Anthony Koupparis, Edward Rowe, Jon Oxley, Jeff M.P. Holly, Claire M. Perks	6
6	Errors in prostate core biopsy diagnosis in an era of specialisation and double reporting 2020 ·Journal of Clinical Pathology ·(unknown), Jon Oxley	2
7	Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web‐based survey by the European Network of Uropathology 2019 ·Histopathology ·Susan Prendeville, Daniel M. Berney, Lukas Bubendorf, Éva Compérat, Lars Egevad, Ondřej Hes, Glen Kristiansen, Jon Oxley, Geert J.L.H. van Leenders, Murali Varma, Theodorus van der Kwast	5
8	Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer 2019 ·BMJ Open ·(unknown), Chris Penfold, (unknown), (unknown), Claire M. Perks, Jeff M.P. Holly, Edward Rowe, Anthony Koupparis, Amit Bahl, Raj Persad, Constance Shiridzinomwa, Lyndsey Johnson, Kalina Biernacka, (unknown), Jayne V. Woodside, Sarah Gilchrist, Jon Oxley, Paul Abrams, J. Athene Lane, Richard M. Martin	10
9	Solitary neurofibroma of the face masquerading as a low-flow vascular malformation – case report and experience of management 2018 ·JPRAS Open ·Stephen R Ali, (unknown), (unknown), Jon Oxley, Robert Warr	1
10	Handling and reporting of transperineal template prostate biopsy in Europe: a web-based survey by the European Network of Uropathology (ENUP) 2018 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Éva Compérat, Lars Egevad, (unknown), Jon Oxley, (unknown), Glen Kristiansen, Daniel M. Berney	3
11	Insulin Receptor Isoform Variations in Prostate Cancer Cells 2016 ·Frontiers in Endocrinology ·Claire M. Perks, Hanna Zielińska, Jing Wang, Caroline Jarrett, (unknown), Michael Ladomery, Amit Bahl, Anthony Rhodes, Jon Oxley, Jeff M.P. Holly	17
12	Pathological analysis of lymph nodes in anterior prostatic fat excised at robot-assisted radical prostatectomy 2014 ·Journal of Clinical Pathology ·(unknown), Ramesh Thurairaja, David Gillatt, Anthony Koupparis, Edward Rowe, Jon Oxley	10
13	Nerve hyperplasia: a unique feature of ketamine cystitis 2013 ·Acta Neuropathologica Communications ·Simon C. Baker, Jens Stahlschmidt, Jon Oxley, Jennifer Hinley, Ian Eardley, Fiona Marsh, David Gillatt, Simon Fulford, Jennifer Southgate	29
14	A M-MLV reverse transcriptase with reduced RNaseH activity allows greater sensitivity of gene expression detection in formalin fixed and paraffin embedded prostate cancer samples 2013 ·Experimental and Molecular Pathology ·(unknown), Anthony Rhodes, Jon Oxley, Michael Ladomery	2
15	Early psychosis treatment in an integrated model within an adult mental health service 2011 ·European Psychiatry ·Melissa Petrakis, (unknown), Jon Oxley, Harold Bloom, David Castle	18
16	Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study 2011 ·British Journal of Cancer ·(unknown), James W.F. Catto, Mary Robinson, Peter C. Albertsen, J R Goepel, Maysam Abbod, D.A. Linkens, Michael Davis, Derek J. Rosario, Anne Y. Warren, Murali Varma, David F. Griffiths, Ken Grigor, Nick Mayer, Jon Oxley, Nayneeta Deshmukh, J. Athene Lane, Chris Metcalfe, Jenny Donovan, David E. Neal, Freddie C. Hamdy	15
17	Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells 2010 ·Nature Cell Biology ·Jonathan W. Astin, Jennifer Batson, Shereen Kadir, Jessica Charlet, Raj Persad, David Gillatt, Jon Oxley, Catherine D. Nobes	201
18	Ketamine cystitis as a mimic of carcinoma in situ 2009 ·Histopathology ·Jon Oxley, Angela M. Cottrell, (unknown), David Gillatt	55
19	Suspected penile cancer: a method to improve handling of pathology specimens 2008 ·British Journal of Urology ·Angela M. Cottrell, (unknown), Jon Oxley	2
20	Role of Pelvic Lymphadenectomy in Prostate Cancer Management 2007 ·Urology ·(unknown), Jon Oxley, (unknown), J.‐U. Stolzenburg, Hartwig Schwaibold	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact